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doi:10.1Objective: Patients with heterotaxy and complex congenital heart disease underwent cardiac surgery with high
mortality and morbidity. Recent studies have revealed an association among heterotaxy, congenital heart dis-
ease, and primary ciliary dyskinesia. We undertook a retrospective review of patients undergoing cardiac surgery
at Children’s National Medical Center between 2004 and 2008 to explore the hypothesis that there is increased
mortality and respiratory complications in heterotaxy patients.
Methods: Retrospective review was performed on postsurgical outcomes of 87 patients with heterotaxy and
congenital heart disease exhibiting the full spectrum of situs abnormalities associated with heterotaxy. As con-
trols patients, 634 cardiac surgical patients with congenital heart disease, but without laterality defects, were
selected, and surgical complexities were similar with a median Risk Adjustment in Congenital Heart
Surgery-1 score of 3.0 for both groups.
Results: We found the mean length of postoperative hospital stay (17 vs 11 days) and mechanical ventilation
(11 vs 4 days) were significantly increased in the heterotaxy patients. Also elevated were rates of tracheostomies
(6.9% vs 1.6%; odds ratio, 4.6), extracorporeal membrane oxygenation support (12.6% vs 4.9%: odds ratio,
2.8), prolonged ventilatory courses (23% vs 12.3%; odds ratio, 2.1) and postsurgical deaths (16.1% vs
4.7%; odds ratio, 3.9).
Conclusions: Our findings show heterotaxy patients had more postsurgical events with increased postsurgical
mortality and risk for respiratory complications as compared to control patients with similar Risk Adjustment in
Congenital Heart Surgery-1 surgical complexity scores. We speculate that increased respiratory complications
maybe due to ciliary dysfunction. Further studies are needed to explore the basis for the increased surgical risks
for heterotaxy patients undergoing cardiac surgery. (J Thorac Cardiovasc Surg 2011;141:637-44)Supplemental material is available online.
Heterotaxy may be defined as a spectrum of discordant or-
gan situs resulting from aberrant left-right axis determina-
tion in the thoracic and abdominal cavities.1 Patients with
heterotaxy often have associated congenital heart disease
(CHD), which is clinically and phenotypically heteroge-
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The Journal of Thoracic and Cawith high mortality, despite advances in surgical and post-
operative care.2 Such patients often have long clinical
courses with a multitude of serious complications, includ-
ing severe hemodynamic instability leading to heart failure,
respiratory failure, and sepsis.3
We have observed that some heterotaxy patients undergo-
ing cardiac surgery develop respiratory complications,
becoming ventilator-dependent and requiring tracheosto-
mies. Our recent finding of a 40% incidence of CHD and
heterotaxy in a mouse model of primary ciliary dyskinesia
(PCD)4 suggested that respiratory complications in hetero-
taxy patients could arise from an etiologic link between het-
erotaxy and PCD. Further consistent with this is a recent
clinical study showing a 6% incidence of heterotaxy among
several hundred PCD patients.5 In light of these observa-
tions, we hypothesized that patients with CHD associated
with heterotaxy may have undiagnosed pulmonary disease
causing increased respiratory complications and increased
mortality. To investigate this possibility, we conducted a ret-
rospective review of postsurgical outcomes in CHD patients
with heterotaxy as compared to similar cardiac patients
without laterality defects.
In two previous retrospective studies on the long-term
outcomes of heterotaxy patients, high surgical mortalityrdiovascular Surgery c Volume 141, Number 3 637
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Dwas reported to be associated with heterotaxy and CHD.6,7
These landmark studies highlighted the striking anatomic
heterogeneity associated with heterotaxy. However,
respiratory complications were not evaluated, and the
studies were limited to patients with left or right atrial
isomerism. In the present study, we defined heterotaxy
more broadly, because some families with situs anomalies
show a recurrence for various birth defects, including
CHD without classic splenic laterality defects.8 We evalu-
ated respiratory complications, including postoperative me-
chanical ventilation, tracheostomy, and extracorporeal
membrane oxygenation (ECMO) support, in addition to
length of hospital stay and postsurgical mortality.PATIENTS AND METHODS
Case and Control Selection
This study was approved and conducted in accordance with the Chil-
dren’s National Medical Center (CNMC) Institutional Review Board.
The cardiothoracic surgical database at CNMC was searched for patients
with heterotaxy or situs inversus who underwent cardiac surgery at
CNMC and had complete mortality data between September 2004 and
May 2008. The remaining patients without evidence of laterality defects
who underwent cardiac surgery in the same time span were evaluated as po-
tential control patients (described as follows). Medical records were
searched for the relevant information. Detailed anatomical information
was obtained via cardiac catheterization reports, cardiac magnetic reso-
nance imaging results, echocardiographic reports, and operative reports.
Thoracic and abdominal situs were determined based on chest radiography,
chest and/or abdominal computed tomography, and abdominal ultrasonog-
raphy. In addition, scintigraphy results were reviewed to determine defini-
tive splenic status, if available. For the case cohort, number and types of
previous operations were also recorded. Finally, data concerning extracar-
diac congenital anomalies were collected frommedical history information
and relevant radiologic results.Definitions and Inclusion Criteria
Heterotaxy in this study is broadly defined as deviation from normal
left-right asymmetry in any thoraco-abdominal organ differing from situs
solitus and situs inversus totalis.9 Therefore, our case cohort is comprised
of patients undergoing cardiovascular surgery with congenital heart defects
associated with abnormal or discordant situs in any organ system typically638 The Journal of Thoracic and Cardiovascular Surgimplicated in laterality disorders, such as pulmonary, cardiovascular, gas-
trointestinal, splenic, and/or hepatobiliary system.
The CHD patients are considered to have abnormal or discordant car-
diovascular situs if they have any of the following: dextrocardia or meso-
cardia, interrupted inferior vena cava, atrial-isomerism/ambiguous/
inversus, atrioventricular discordance, superior/inferior ventricles, and
ventricular-arterial discordance. In contrast, isolated cases of congenital
heart defects, such as double outlet right ventricle with no other situs de-
fects, were excluded. Inclusion criteria for laterality associated defects in
noncardiovascular organs included: bronchial airway/pulmonary isomer-
ism or inversus, midline or left-sided liver, midline or right-sided stomach,
right-sided spleen, polysplenia or asplenia.Outcome Data Collection
For the case group, detailed surgical data and postsurgical outcome data
were recorded from discharge summaries, progress notes, respiratory care
data sheets, and operative reports. Types of surgical operations, particulary
single ventricle (SV) versus biventricular (BiV) surgical tracks and their
Risk Adjustment in Congenital Heart Surgery (RACHS-1) scores were de-
tailed.10 RACHS-1 scores have been shown to correlate well with in-
hospital mortality and length of postoperative hospital stay, thus allowing
for relevant comparisons between different groups undergoing surgery
for CHD.11 Post-surgical mortality, defined by death within 30 postopera-
tive days or within the postoperative hospital stay, was collected via the car-
diothoracic surgical database or death certificates in the electronic medical
records. Postoperative respiratory outcomes, including length of mechani-
cal ventilation (total days, even if extubated for a day or days in between
intubations), and serious unexpected postoperative events, such as the
need for tracheostomy placement (usually unsuccessful extubation after
1 month), and ECMO support for cardiorespiratory failure were gathered.
A prolonged ventilatory course was defined as postoperative mechanical
ventilation greater than 10 days based on analyzing the distribution of post-
operative mechanical ventilatory duration during the same period in all pa-
tients following cardiac surgery, which represents the upper 10% of cases.
This definition of a prolonged ventilatory course has been used previously
in a pediatric cardiac surgical population.12 For the control patients group,
similar data were collected as available.Statistical Analysis
Data are summarized with standard deviations, medians with interquar-
tile ranges (25th-75th percentile), frequencies, and ranges. The c2 test was
used to study categorical variables and odds ratios for serious unexpected
events. TheWilcoxon rank sum test was used in comparing continuous var-
iables. The Fisher-Freeman-Halton’s exact test (a generalized version of
Fisher exact test) is used to compare whether the probabilities of each post-
surgical events are equal among 5 subgroups with different splenic status,
and the Kruskal-Wallis analysis of variance test is used to compare the
median of the continuous outcomes among these 5 splenic subgroups.
Time-to-event distribution plots were constructed using the Kaplan-
Meier product-limited method and were compared by log-rank statistics.
The generalized estimating equation (GEE) regression models were
applied to estimate the odds ratio of unexpected postsurgical events and
the difference of length of mechanical ventilation and length of postoper-
ative hospital stay for the case versus control group, respectively. The
GEE procedures used individual surgery information for each patient, tak-
ing into account correlation of outcomes among the surgical procedures in
each patient and different numbers of procedures per patient. The multivar-
iate GEE models were adjusted for potential baseline predictors, including
age at surgery, and gender and surgical variables, such as surgical tracks,
surgeon, and the categorical RACHS-1 scores. The quadratic term of age
at surgery was included if it is tested to be significant. Analyses were per-
formed with SAS version 9.0 (SAS Institute Inc, Cary, NC) and the
StatXact-8 (Cytel Inc, Cambridge, Mass).ery c March 2011
TABLE 1. Cardiovascular anatomy and organ situs
Cardiovascular anatomy n (%)
Organ situs
arrangements n (%)
Cardiac position Heart
Dextrocardia 36 (41) Normal 42 (48)
Mesocardia 9 (10) Opposite 36 (41)
Venous anomalies Midline 9 (10)
Interrupted inferior vena cava 11 (13) No record 0
Bilateral superior vena cavae 38 (44) Stomach
Anomalous pulmonary venous return 11 (13) Normal 65 (75)
Atria and ventricles Opposite 20 (23)
Atrioventricular discordance 40 (46) Midline 1 (1)
Atrioventricular septal defect 28 (32) No record 1 (1)
Single ventricle morphology 59 (68) Liver
Atrial septal defect 54 (62) Normal 46 (53)
Ventricular septal defect 62 (71) Opposite 8 (9)
Atrioventricular valve stenosis/atresia 10 (11) Midline 27 (31)
Ebstein’s malformation 6 (7) No record 6 (7)
Ventricular outflow and great vessels Spleen
Ventriculoarterial discordance 66 (70) Normal 27 (31)
Double-outlet right ventricle 29 (33) Right-sided 5 (6)
Pulmonary stenosis or atresia 55 (63) Asplenia 18 (21)
Truncus arteriosus 2 (2) Polysplenia 6 (7)
Aortic stenosis 2 (2) No record 31 (36)
Coarctation of the aorta 4 (5) Gastrointestinal tract
Right aortic arch 24 (28) Normal 11 (13)
Van Praagh classification Biliary atresia 3 (3)
{S,D,S} 13 (15) Malrotation 13 (15)
{S,D,D} 14 (16) No record 60 (69)
{S,L,L} 28 (32) Lungs
{S,D,A} 2 (2) Normal 1 (1)
{S,D,X} 1 (1) Inverted 0
{S,D,L} 2 (2) Left isomerism 3 (3)
{S,L,X} 1 (1) Right isomerism 1 (1)
{I,L,L} 6 (7) No record 82 (94)
{I,D,I} 1 (1)
{I,D,D} 1 (1)
{I,L,X} 2 (2)
{A,D,D} 10 (11)
{A,L,L} 3 (3)
{A,D,S} 2 (2)
{A,D,L} 1 (1)
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DRESULTS
Eighty-seven patients with CHD and heterotaxy were se-
lected as cases using the broad definition of heterotaxy
noted previously. The spectrum of congenital heart defects
included in the case group is detailed in Table 1. The pa-
tients ranged from 1 day of life to 30.8 years of age at the
time of initial operation (median age, 9.8 months; mean
age, 3.9 years). Thirty-one percent were Black, reflective
of the overall patient population seen at CNMC, and 23%
were Arab, a reflection of CNMC’s surgical partnership
with Middle Eastern cardiac centers (Table E1).
From the same cardiac surgical patient population, 634
patients with CHD, not associated with discernable lateralityThe Journal of Thoracic and Cadefects, were selected as control patients. Excluded patients
included those with isolated patent ductus arteriosus (PDA)
closures, heart transplants, isolated pacemaker revisions, and
cases involving isolated ECMO procedures, as their clinical
profiles were not reflected in our case cohort. Ages at initial
operation ranged from 1 day of life to 64.4 years of age (me-
dian age, 6.2 months; mean age, 3.8 years). Overall, 44%
were White, 30% Black, 14% Hispanic, 7% Arab, and 3%
Asian, with the remaining 3% unclassified (Table E1).
Cardiovascular Defects in Patients With Heterotaxy
Among case participants, levocardia was present in 42
patients (48%), whereas 45 patients (52%) had abnormalrdiovascular Surgery c Volume 141, Number 3 639
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Dcardiac positions of which dextrocardia accounted for 36
cases (41%), and mesocardia for 9 cases (10%). Atrial situs
solitus was seen in 61 patients (70%), inversus in 10 pa-
tients (11%), and ambiguous in 16 patients (18%). Of the
16 patients with ambiguous atrial situs, left isomerism
was diagnosed in 5 patients (6%) and right isomerism in
1 patient (1%), whereas the remaining 10 patients were
not further evaluated. Ventricular looping was D-looped
in 40 patients (46%) and L-looped in 47 patients (54%). Fi-
nally, the situs of the great vessels was solitus in 15 patients
(17%), dextroposed in 25 patients (29%), levoposed in 40
patients (46%), and inverted in 1 patient (1%). Of note, 2
patients (2%) had anterior/posterior malposition of the
great vessels, and the situs of the great vessels could not
be determined in another 4 patients (4%), usually due to
prior surgery on the pulmonary trunk. Table 1 summarizes
the cardiac defects in the case cohort, as well as their seg-
mental analysis.13TABLE 2. Extracardiac anomalies in heterotaxy patients
Organ system n
Percentage
of cases
Gastrointestinal
Extrahepatic biliary atresia 3 3
Malrotation of the gut 14 16
Esophageal atresia 3 3
Duodenal atresia 1 1
Imperforate anus 1 1
RespiratoryVisceral Organ Situs in Patients With Heterotaxy
Specifics of situs determinations were made using the
available imaging results (Table 1). When records were
available, laterality abnormalities compared to normal
were seen as present in heart position (51%), in the abdom-
inal organs (70%), and bronchial airway/lung isomerism
(80%) of the few pulmonary imaging records in these het-
erotaxy patients. For the abdominal organs abnormal posi-
tion or absence was seen for the stomach (24%), the liver
(43%), the gastrointestinal tract (59%), the spleen (60%)
(right-sided [not polysplenia]) (6%), asplenia (21%), and
polysplenia (7%). Analysis showed that for our 4 dichoto-
mous and 2 continuous postoperative outcomes there were
no statistical differences in the event rate of these outcomes
among different subgroups (Table E2).Absence/hypoplasia of one lung 2 2
Tracheoesphageal fistula 2 2
Tracheomalacia 1 1
Choanal stenosis 1 1
Neurologic
Myelomeningocele 1 1
Hydrocephalus 1 1
Genitourinary
Absence of one kidney 1 1
Pelvic kidney 2 2
Polycystic kidney 1 1
Horseshoe kidney 1 1
Other 3 3
Musculoskeletal
Cleft lip or palate 2 2
Other 5 6
Chromosomal/syndromic
Trisomy 21 2 2
Inverted chromosome 9 1 1
DiGeorge syndrome 1 1
Vater/vacterl 3 3Clinical Characteristics of Patients With Heterotaxy
Fifty-six of 87 heterotaxy patients (64%) had prior surgi-
cal operations, with 37 (43%) having had cardiac surgery.
The mean number of previous cardiac surgical procedures
was 1 (range, 0-5). Thirteen patients (15%) required hospi-
talization for pneumonia in the neonatal period, and another
2 patients had a previous history of another lower respira-
tory infection requiring hospitalization. Of note, 37 of 45
patients (82%) with available records from the newborn pe-
riod had a history of neonatal respiratory distress. Gesta-
tional histories were reviewed as available and pertinent
results are summarized in Table E3. Complicated pregnan-
cies were found in 24 of 47 patients. Overall, prenatal diag-
noses were made in 28 of 54 patients (52%) with available
records. Prenatal diagnosis of congenital heart disease was
made in 27 patients (50%), multiple extracardiac anomalies
in 3 patients (6%), heterotaxy in 2 patients (4%), as well as
isolated cases of asplenia, duodenal atresia, and supraven-640 The Journal of Thoracic and Cardiovascular Surgtricular tachycardia (Table E4). All patients with splenic ab-
normalities received antibiotic prophylaxis.
The incidence of various noncardiac structural abnormal-
ities was high in heterotaxy cases (Table 2). Forty-two of 87
heterotaxy cases (48%) cases have extracardiac anomalies
and 45 (52%) have no extracardiac anomalies. The medians
RACHS-1 scores in the group of patients with or without
extracardiac anomalies are 3.0 (range, 1.0-6.0) and 3.0
(range, 2.0-6.0), respectively. Thus, the RACHS-1 scores
are found to be similar and comparable between the two
groups of heterotaxy patients with or without extracardiac
anomalies (P¼ .8). In the multivariate model for the 87 het-
erotaxy cases only, the presence of extracardiac anomalies
is not significantly associated with the risk of postsurgical
mortality (P¼ .12) after adjusted for the patient’s age, gen-
der, and RACHS-1 score.
Surgical Management Heterotaxy and Control
Patients
Heterotaxy patients underwent 123 cardiac surgical oper-
ations (Figure 1, A). Sixty-two patients (71%) followed
a single ventricle track. Another 22 patients (25%) under-
went BiV repair. The median RACHS-1 scores for these op-
erations under the single and BiV repair tracks were bothery c March 2011
FIGURE 1. Flow charts summarizing the operative tracks for heterotaxy
patients (A) and control patients (B). Other refers to noncardiovascular by-
pass operations. Surgery involving multiple operations (ie, Total anoma-
lous pulmonary venous connections correction and Glenn operation)
were segregated for clarity. In addition, data concerning Risk Adjustment
in Congenital Heart Surgery (RACHS-1) scores for each track are included
as follows. ASD, Atrial septal defects; AVSD, atrioventricular septal
defects; BDG, bidirectional Glenn; BT, Blalock-Taussig; CoA, coarctation;
DKS, Damus-Kaye-Stansel; PA, pulmonary artery; TAPVC, total anoma-
lous pulmonary venous connections; TOF, tetralogy of Fallot; VSD, ven-
tricular septal defects.
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D3.0 (mean, 2.9; range, 1-6). The remaining 3 patients (3%)
underwent vascular operations, including a PDA ligation,
aortopexy, and vascular ring repair. For this latter group,
the median RACHS-1 score for these 4 operations was 1.5
(Figure 1, A). In the control patients group, underwent
715 cardiac surgeries at CNMC during this time span
(Figure 1, B). The median RACHS-1 scores for both surgi-
cal tracks were 3.0 (mean, 2.7; range, 1-6), as in the caseThe Journal of Thoracic and Caheterotaxy groups. The nonprimary cardiac surgical opera-
tions in heterotaxy patients undergoing single ventricle or
BiV repairs are listed in Tables E5 and E6, respectively.
Because we had a greater number of SV surgical track
patients in the heterotaxy group compared to the control
patients group (Figures 1, A and B), we investigated the con-
founding effects of single versus BiV patients on our results.
For the heterotaxy cases, we have 62 SV track (71%), 20
BiV surgical track (with a possible effect of 23%), and 5
vascular surgery patients (6%). For the controls, we have
96 SV (15%), 515 BiV (81%), 23 vascular patients (4%).
As expected, the distribution of this variable is significantly
different between cases and control patients (P<.01). Mul-
tivariate analysis of this important variable (the surgical
track) showed SV patients did not have worse postoperative
events compared to BiV patients (Tables 3 and E7).
Postsurgical Outcomes in Heterotaxy Versus Control
Patients
One hundred fifty-three patients (39 cases and 114 con-
trols) underwent multiple (2 to 5) major surgeries in the
same or different surgical stays. Age at initial surgery and
gender were not statistically different between the two
groups (Table E1). The RACHS-1 scores for the case and
control groups were also not significantly different (Table
4). The race distribution between case and controls could
not be compared statistically because race assignment was
not available for 30% of the controls.
The median postoperative hospital stay for the 87 cases
was 10 days (mean, 17.3 days) (Table 4). In comparison,
the postoperative hospital stay for the control patients
group was significantly shorter (P<.0001), with a median
of 6 days and mean of 10.8 days. The median length of
postoperative mechanical ventilation for heterotaxy cases
was 1.4 days (mean, 11.1 days) (Table 4), with 23 patients
(20%) experiencing prolonged ventilatory courses follow-
ing their surgical operation (Table 5). In comparison, the
length of postoperative mechanical ventilation for the con-
trols was significantly shorter (P ¼ .01), with median of
1.2 days and mean of 4.0 days (Table 3), with a smaller
proportion of controls (12.3%, 78 patients) experiencing
prolonged ventilatory courses (Table 5). The distribution
plots for length of mechanical ventilation and length of
postoperative hospital stay for the two groups showed
that patients with heterotaxy associated with CHD have
significantly longer postoperative lengths of mechanical
ventilation (P ¼ .003) and hospital stay (P< .0001) than
the control patients group (Table 3, Figure E1).
The frequency of serious unexpected postsurgical
events including deaths, ECMO procedures, tracheosto-
mies, and prolonged ventilatory courses was compared be-
tween the cases and controls and are shown in Table 5. All
four postsurgical events were significantly more common
among the heterotaxy patients who had an increased riskrdiovascular Surgery c Volume 141, Number 3 641
TABLE 3. Adjusted odds ratios and mean differences in postsurgical events and outcomes between heterotaxy patients and controls*
Postsurgical event Adjusted odds ratio* 95% CI P valuey
Postsurgical death 2.7 1.1–6.4 .024
ECMO requirement 3.0 1.2–7.1 .015
Tracheostomy 4.3 1.2–16.2 .030
Prolonged ventilatory course 2.9 1.5–5.7 .003
Postsurgical outcome Adjusted mean difference* 95% CI P valuez
Log (days of mechanical ventilation) 0.46 0.2–0.73 .0006
Log (days of postoperative hospital stay) 0.16 0.01 to 0.34 .072
CI, Confidence interval; GEE, generalized estimating equation. *Estimated from GEE regression models that adjusted for age at surgery, gender, surgeon and the categorical
RACHS-1 scores and surgical track. The quadratic term of age at surgery was included if tested to be significant (see Table E7). yThe P value for the c2 test of the hypothesis
that the odds ratio is 1. zThe P value for the t-test of the hypothesis that the difference is zero.
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Dof postsurgical death (16.1% vs 4.7%; odds ratio [OR],
3.9; P< .0001), increased ECMO requirement (OR, 2.8;
P ¼ .004), increased tracheostomy rate (OR, 4.6;
P ¼ .002), and increased rate of prolonged ventilatory
course (OR, 2.1; P ¼ .006). Table 3 shows the results
from multivariate regression models after adjustment for
age at surgery, gender, surgeon, RACHS-1 score, and
the SV vs BiV surgical track. Controlling for these possi-
ble confounding variables, the heterotaxy patients, when
compared to the control patients, still have significantly
increased risks for postsurgical death (OR, 2.7), ECMO
requirement (OR, 3.0), tracheostomy (OR, 4.3), prolonged
ventilatory course (OR, 2.9), and for having increased
length of postoperative mechanical ventilation (mean log
difference of 0.46; P< .001), and a trend of longer post-
operative hospital stay (mean log difference of 0.16;
P ¼ .07). It should be noted that multivariate regression
analysis also showed younger age and higher RACHS-1
score are independent predictors of increased risk of
death, ECMO, prolonged ventilatory course, longer days
of ventilation, and longer hospital stay (Table E7).TABLE 4. Comparison of postsurgical outcomes and overall RACHS-1 sc
Cases* (n ¼ 87)
Postsurgical outcome Median (IQR) Mean (SD
Length of postoperative
hospital stay (d)
10 (6–21) 17.3 (20.9)
Length of mechanical
ventilation (d)
1.4 (1.0–6.5) 11.1 (35.4)
RACHS-1 category N %
1 5 4.2
2 40 33.9
3 59 50.0
4 8 6.8
5 0 0.0
6 6 5.1
IQR, Interquartile range; RACHS-1, Risk Adjustment in Congenital Heart Surgery; SD, sta
surgical outcomes were obtained by averaging values of surgeries within each patient and t
sum test was used to compare the median between cases and control patients because the dis
to compare the distribution of the RACHS-1 categories between cases and controls.
642 The Journal of Thoracic and Cardiovascular SurgDISCUSSION
Retrospective review of postsurgical outcomes in 87 pa-
tients with heterotaxy and complex CHD undergoing car-
diac surgery revealed more complicated courses, with
increased respiratory complications as compared to 634 car-
diac surgery patients with CHD, but no laterality defects.
Overall, case and control patient groups had similar
RACHS-1 scores, indicating both groups underwent cardiac
operations of similar complexity and with similar antici-
pated mortality risks. However, we observed an increase
in postsurgical mortality in heterotaxy patients.
Most of the heterotaxy patients underwent single ventri-
cle repair, not unexpected as BiV repair is often precluded
in patients with complex cardiovascular anatomy. Contrary
to our clinical expectations, the SV surgical track did not
lead to worse postoperative outcomes in heterotaxy pa-
tients. Our control patient population underwent various
high-risk operations that are comparable to those in hetero-
taxy patients. For example, high-risk surgery with the max-
imal RACHS-1 score of 6 (mainly Norwood Stage 1
operations) accounted for 5% of all operations in bothores in heterotaxy patients and controls
Control patients* (n ¼ 634)
P Valuey) Median (IQR) Mean (SD)
6 (4–11) 10.8 (13.2) <.0001
1.2 (0.6–3.0) 4.0 (8.4) .01
N %
58 8.4 .32
247 36.0
284 41.3
61 8.9
0 0.0
37 5.4
ndard deviation. *For patients with multiple surgeries, the mean and median of post-
hen taking the median and the average between patients. yThe 2-sided Wilcoxon rank
tribution of the outcomes were skewed with few very large values. The c2 test was used
ery c March 2011
TABLE 5. Unexpected postsurgical events in heterotaxy patients and control patients
Cases (n ¼ 87) Control patients (n ¼ 634)
Odds ratio 95% CI P value*Postsurgical event n (%) n (%)
Postsurgical death 14 (16.1) 30 (4.7) 3.9 2.0–7.6 <.0001
ECMO requirement 11 (12.6) 31 (4.9) 2.8 1.4–5.8 .004
Tracheostomy 6 (6.9) 10 (1.6) 4.6 1.6–13.1 .002
Prolonged ventilatory course 20 (23.0) 78 (12.3) 2.1 1.2–3.7 .006
CI, Confidence interval; ECMO, extracorporeal membrane oxygenation. *The P value for the c2 test of the hypothesis that the odds ratio is 1.
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Dcase and control patient groups. In addition, operations with
RACHS-1 scores greater than 3 were performed in 14% of
controls and 12% of cases. Our multivariate analysis of the
cases showed an association between increased risk of post-
surgical mortality with younger age and higher RACHS-1
score, a result that is consistent with previous studies.14
Significant increases in the length of postoperative hospi-
tal stay and postoperative mechanical ventilation were ob-
served in the heterotaxy patients. Postsurgical outcome
comparisons also showed an increased incidence of trache-
ostomies, prolonged ventilatory courses, and increased
postoperative ECMO support. Heterotaxy patients also
had a high incidence of neonatal respiratory distress and
pneumonia, despite antibiotic prophylaxis for splenic ab-
normalites. We note that respiratory complications in pa-
tients with CHD are often attributed to congestive heart
failure, infections,15 or pulmonary venous anomalies,16,17
some with obstruction.18 We previously proposed hetero-
taxy patients with CHDmay have respiratory complications
related to ciliary dysfunction, as a mouse model of PCD ex-
hibited a high incidence of heterotaxy.4 Moreover, a 6%
prevalence of heterotaxy was observed in a clinical study
of PCD patients.5
The cardiovascular anomalies seen in the heterotaxy pa-
tients highlight the severity of CHD often associated with
laterality defects. There was a high incidence of single ven-
tricle morphologies (68%), atrioventricular discordance
(46%), and ventriculoarterial discordance (76%). Of note,
we classified atrial situs arrangements in these patients as
solitus, inversus, or ambiguous rather than using atrial isom-
erism status. Various approaches have been used to classify
heterotaxy, with one approach focusing on right versus left
atrial isomerism as defined by differing characteristics of
the atrial pectinate muscles and its association with asplenia
or polysplenia, respectively (Anderson and colleagues19). A
broader definition of asplenia/ploysplenia syndromes uses
the combined characteristics of atrial isomerism, as delin-
eated by atrial appendage morphology in conjunction with
vena cavae and coronary sinus returns to the atria.6,7 Yet
another nomenclature uses a segmental approach to define
left-right patterning of the atria, ventricles, and outflow ar-
teries.13 In this study, we defined heterotaxy as abnormal
left-right positioning of any thoraco-abdominal organ.9
This broad definition allows integration of the complex al-
terations in cardiac anatomy with other situs defects. Anal-The Journal of Thoracic and Caysis of visceral organ situs arrangements in our patients
showed a high incidence of dextrocardia, midline livers,
splenic abnormalities, and gastrointestinal malrotation. Us-
ing our definition of heterotaxy, a strong correlation was ob-
served with heterotaxy showing increased postoperative
mortality and respiratory complications. Splenic abnormal-
ities, often used to categorize heterotaxy patients, were not
better correlated with postoperative outcomes.
Limitations
There are many limitations to our analysis that warrant
consideration. In any study, it is difficult to evaluate all of
the confounding variables in the postoperative critical
care period. In this retrospective study, respiratory vari-
ables, such as extubation failure rates, pulmonary infec-
tions, phrenic nerve paresis, and pulmonary mechanics
were often not available for cases and control patients.
There were also insufficient data on noncardiac anomalies
and splenic status in the control patients group. Residual
cardiac abnormalities also could not be controlled between
cohorts. Nevertheless, the findings from this study provide
new insights regarding the morbidity and mortality of heter-
otaxy patients undergoing cardiovascular surgery.
Future Studies
Further studies in the future are needed to explore the un-
derlying cause for the increased respiratory complications
in heterotaxy patients and whether this may involve ciliary
dysfunction. This is perhaps not unexpected, as the mecha-
nistic link between PCD and heterotaxy revolves around
two distinct types of motile cilia. In the case of PCD, muco-
ciliary clearance defects would arise from immotile or dys-
kinetic motion associated with the cilia of the airway
mucosa. In contrast, with heterotaxy, left-right patterning
defects could arise from altered function associated with
motile cilia in the embryonic node.20 It should be noted
that several heterotaxy patients exhibited extracardiac
anomalies known to be associated with ciliary dysfunction,
such as polycystic kidney disease, hydrocephalus, hearing
deficits, neonatal respiratory distress, and recurrent ear
and sinopulmonary infections.21 If there is evidence of cil-
iary dysfunction in heterotaxy patients, then the standard of
care for such patients might include presurgical clinical as-
sessment for ciliary dysfunction and instituting aggressive
preoperative pulmonary therapy and postsurgicalrdiovascular Surgery c Volume 141, Number 3 643
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Dmanagement of respiratory/pulmonary function to improve
outcome and reducemortality for these congenital heart dis-
ease patients undergoing high-risk cardiac surgeries.References
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FIGURE E1. Time -to-event distribution plots for postoperative length of
hospital stay (A) and postoperative mechanical ventilation (B) for hetero-
taxy patients (solid line) and control patients (dashed line).
TABLE E1. Demographics of heterotaxy cases and control patients
Factor Cases Controls P value
Age at initial operation
Mean  SD (y) 3.9  6.0 3.8  7.4
Median (IQR [y]) 0.81 (0.04–6.5) 0.52 (0.12–3.7) .5
Gender n (%) n (%)
Male 47 (54) 350 (55)
Female 40 (46) 284 (45) .8
Race n (%) n (%)
Black 27 (31) 133 (30)
Arab 20 (23) 29 (7)
White 19 (22) 195 (44)
Hispanic 8 (9) 64 (14)
Asian 7 (8) 12 (3)
Other 6 (7) 12 (3) .001
SD, Standard deviation; IQR, interquartile range.
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TABLE E3. Gestational data for heterotaxy patients
Factor n Mean Median Range
Gestational age (months) 46 37.4 37.4 32–41
Birth weight (kg) 44 2.85 2.86 1.35–4.11
Factor Yes No Unknown
Percentage with
positive result
Pregnancy complications 24 23 40 51
Prenatal diagnoses 28 26 33 52
History of neonatal
respiratory distress
37 8 42 82
TABLE E2. Analyses of heterotaxy splenic subgroups
Normal
(N ¼ 27)
Right
(N ¼ 5)
Asplenia
(N ¼ 18)
Polysplenia
(N ¼ 6)
No record
(N ¼ 31)
Total
(N ¼ 56) P*
Postsurgical event N (%)
Postsurgical death 4 (29%) 0 (0%) 4 (29%) 2 (14%) 4 (29%) 14 (100%) .58
ECMO requirement 3 (27%) 0 (0%) 4 (36%) 0 (0%) 4 (36%) 11 (100%) .71
Tracheostomy 4 (67%) 1 (17%) 1 (17%) 0 (0%) 0 (0%) 6 (100%) .09
Prolonged ventilator course 8 (40%) 1 (5%) 5 (25%) 2 (10%) 4 (20%) 20 (100%) .47
Postsurgical outcome Median (IQR)
Days of mechanical ventilation) 1.6 (0.8–2.1) 1.0 (0.9–3.1) 1.6 (1.1–5.2) 3.5 (1.1–9.9) 1.2 (1.0–4.1) 1.3 (1.0–6.5) .71
Days of postoperative hospital stay) 13.0 (6–23) 10.0 (8–19) 9.2 (6–21) 24.5 (14–30) 8.5 (6–19) 10.0 (6–21) .34
ECMO, Extracorporeal membrane oxygenation; IQR, interquartile range. *The Fisher-Freeman-Halton’s exact test (a generalized version of Fisher exact test) is used to compare
whether the probabilities of each postsurgical event are equal among five subgroups with different splenic status; and the Kruskal-Wallis test is used to compare the median of the
continuous outcomes among these five splenic subgroups.
TABLE E4. Prenatal complications and diagnoses for heterotaxy
patients
Type of complication n Percentage of cases
Gestational diabetes 11 23
Twin gestation 4 9
Gestational hypertension 3 6
Polyhydramnios 2 4
In vitro fertilization 2 4
Oligohydramnios 1 2
Placenta previa 1 2
Maternal pituitary tumor 1 2
Protein S deficiency 1 2
Antiphospholipid syndrome 1 2
Prenatal diagnosis n Percentage of cases
CHD 27 31
Multiple extracardiac anomalies 3 3
Heterotaxy 2 2
Asplenia 1 1
Duodenal atresia 1 1
Supraventricular tachycardia 1 1
CHD, Congenital heart disease.
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TABLE E5. Other cardiac surgical operations in heterotaxy patients
undergoing single ventricle repair
Surgical operation n
Kawashima procedure 2
TAPVC repair 2
TAPVC repair with cavopulmonary anastomosis 2
TAPVC repair with BT shunt 1
PAPVR repair 1
Central shunt 1
Conduit replacement (hepatic veins to PA) 1
Coarctation of the aorta repair 1
Coarctation of the aorta repair with PA band 1
Pulmonary venous stenosis repair 1
Aortic aneurysm repair, truncus arteriosus repair, and BT shunt 1
Pacemaker implantation 1
BT, Blalock-Taussig; PA, pulmonary artery; PAPVR, partial anomalous pulmonary
venous connections; TAPVC, total anomalous pulmonary venous connections.
TABLE E6. Other cardiac surgical operations in heterotaxy patients
undergoing biventricular repair
Surgical operation n
RV-PA conduit replacement 2
Pacemaker implantation 2
TAPVC repair and Tetralogy of Fallot repair 1
AVSD repair 1
Modified Konno procedure 1
VSD closure and tricuspid annuloplasty 1
Right ventricular outflow tract reconstruction 1
Mitral valve replacement 1
Pulmonary vein stenosis repair 1
LV-PA conduit replacement 1
AVSD, Atrioventricular septal defect; LV-PA, left ventricular to pulmonary artery; RV-
PA, right ventricular to pulmonary artery; TAPVC, total anomalous pulmonary venous
connections; VSD, ventricular septal defect.
TABLE E7. P values for the multivariate models of postoperative events
P value
Postsurgical event Case vs control patients Age Age squared Gender RACHS Surgeon Surgical track
Postsurgical death .024 .031 .33 .48 .007 .63 .29
ECMO requirement .015 .038 .77 .25 <.0001 .16 .18
Tracheostomy .030 .17 .80 .55 .94 .91 .53
Prolonged ventilatory course .0027 .0001 .0002 .085 <.0001 .34 .39
Postsurgical outcome
log (days of mechanical ventilation) .0006 <.0001 <.0001 .064 <.0001 .33 .59
log (days of post operative stay) .072 <.0001 <.0001 .015 <.0001 .066 .0002
RACHS, Risk Adjustment in Congenital Heart Surgery.
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